- This application is designed for academic investigators and private research groups interested in performing a screen at ICCB-Longwood.
- A new application must be submitted for each screen that is proposed at ICCB-L. If you have a project that you would like to screen at ICCB-L and do not have an assigned screen number, please complete the following application form.
- Please review all of the information on this page before you submit an application for screening at ICCB-Longwood.
We are currently accepting applications on a rolling basis. If the facility becomes oversubscribed, we will institute a waiting list.
A fee is charged for access to small molecule screening at ICCB-Longwood, please see the Small Molecule Fees section for details.
Before screening, you will need to review and agree to the ICCB-Longwood protocol and data sharing policies outlined in the ICCB-Longwood Small Molecule User Agreement. We must have a signed copy for each collaborator before use of ICCB-Longwood is scheduled. Note that if you are carrying out both small molecule and RNAi screens at ICCB-Longwood, you need to complete both a small molecule and RNAi user agreement.
We do our best to avoid situations in which two different groups are carrying out substantially similar screens on the same compound collections at the same time. The decision as to whether a proposed screen will compete with ongoing assays is made by the ICCB-Longwood Screen Review Committee in consultation with the investigators involved. Precedence is generally given to the screen first proposed and initiated.
Often, investigators request a letter of support for grants intended to fund a screen. Please understand that we can only write such a letter if we know we can accommodate your screen. Thus, please try to submit your screen application well in advance of grant deadlines and notify us if you would like a letter of support.
Please send any questions about the ICCB-Longwood Screening Application or evaluation process to firstname.lastname@example.org or Jennifer Smith. Thank you.